1. Home
  2. USPH vs PLSE Comparison

USPH vs PLSE Comparison

Compare USPH & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USPH
  • PLSE
  • Stock Information
  • Founded
  • USPH 1990
  • PLSE 2014
  • Country
  • USPH United States
  • PLSE United States
  • Employees
  • USPH N/A
  • PLSE N/A
  • Industry
  • USPH Medical/Nursing Services
  • PLSE Medical/Dental Instruments
  • Sector
  • USPH Health Care
  • PLSE Health Care
  • Exchange
  • USPH Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • USPH 1.2B
  • PLSE 1.3B
  • IPO Year
  • USPH 1992
  • PLSE 2016
  • Fundamental
  • Price
  • USPH $74.81
  • PLSE $15.85
  • Analyst Decision
  • USPH Strong Buy
  • PLSE
  • Analyst Count
  • USPH 4
  • PLSE 0
  • Target Price
  • USPH $109.00
  • PLSE N/A
  • AVG Volume (30 Days)
  • USPH 132.8K
  • PLSE 172.8K
  • Earning Date
  • USPH 05-06-2025
  • PLSE 05-06-2025
  • Dividend Yield
  • USPH 2.46%
  • PLSE N/A
  • EPS Growth
  • USPH 43.97
  • PLSE N/A
  • EPS
  • USPH 1.84
  • PLSE N/A
  • Revenue
  • USPH $664,433,000.00
  • PLSE N/A
  • Revenue This Year
  • USPH $14.00
  • PLSE N/A
  • Revenue Next Year
  • USPH $6.39
  • PLSE N/A
  • P/E Ratio
  • USPH $39.79
  • PLSE N/A
  • Revenue Growth
  • USPH 10.99
  • PLSE N/A
  • 52 Week Low
  • USPH $72.27
  • PLSE $6.60
  • 52 Week High
  • USPH $113.63
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • USPH 33.11
  • PLSE 33.47
  • Support Level
  • USPH $72.27
  • PLSE $15.57
  • Resistance Level
  • USPH $75.01
  • PLSE $16.99
  • Average True Range (ATR)
  • USPH 2.27
  • PLSE 0.99
  • MACD
  • USPH -0.23
  • PLSE -0.05
  • Stochastic Oscillator
  • USPH 21.75
  • PLSE 26.21

About USPH U.S. Physical Therapy Inc.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: